| 000 | 00986 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513174411.0 | ||
| 264 | 0 | _c19990519 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a1073-2322 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTracey, K J | |
| 245 | 0 | 0 |
_aFrom mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? _h[electronic resource] |
| 260 |
_bShock (Augusta, Ga.) _cMar 1999 |
||
| 300 |
_a224-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aSepsis _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aAbraham, E | |
| 773 | 0 |
_tShock (Augusta, Ga.) _gvol. 11 _gno. 3 _gp. 224-5 |
|
| 999 |
_c10148251 _d10148251 |
||